Saturday, 23rd of January 2016 |
Emerging arboviruses in the Pacific [Dengue, Zika, chikungunya]
Didier Musso
Best viewed at http://dx.doi.org/10.1016/S0140-6736(14)61977-2
The Lancet,Volume 384, No. 9954, p1571–1572, 1 November 2014
Correspondence
Dengue virus is the causal agent of dengue fever and is typically characterised by fever, myalgia, arthralgia, rash, and sometimes severe and life-threatening clinical symptoms. This virus is regarded as the greatest threat to global public health of arthopod-borne viruses (arboviruses). However, during the past decade additional mosquito-borne viruses, including chikungunya virus, which causes fever and acute polyarthralgia, have successfully expanded to geographical areas where only dengue epidemics used to be reported, particularly to the tropical oceanic regions. In 2005, chikungunya virus was recorded in the Indian Ocean islands, and from the end of 2013, reached the Caribbean.1 In 2014, concomitant outbreaks have happened in the Pacific due to dengue virus, chikungunya virus, and Zika virus—another mosquito-borne virus that mostly causes mild fever, joint pain, conjunctivitis, and rash.2, 3, 4
Substantial changes in epidemiology of mosquito-borne diseases in tropical oceanic regions are probably caused by many and difficult to address factors. However, a review of the epidemiological situation in the Pacific from the past several years shows that the present crisis could be the product of a gradual process. In the Pacific the situation worsened during a 7-year period; the predominant circulation of a single dengue virus serotype (dengue virus serotype [DENV]-1) changed to co-circulation of several virus serotypes (DENV-4 in 2007, then also with DENV-2, which caused some sporadic outbreaks, and co-circulation of DENV-3 in 2013),2 and concurrent emergence of mosquito-borne viruses not previously reported in the region (figure).
Figure
Expansion of dengue, chikungunya, and Zika viruses in Pacific Island countries and territories between 2007 and 2014
Isl=island. Plot marks represent the occurrence of an outbreak. Imported cases from the Pacific with mosquito-borne viral infection confirmed back to their home country were not reported if additional information on the possible occurrence of an outbreak in the Island Country visited was not available. Data (up to September, 2014) are from ProMED (http://www.promedmail.org), WHO western Pacific Region (http://www.wpro.who.int/southpacific/), Pacific Public Health Surveillance Network (http://www.spc.int/phs/PPHSN; http://www.spc.int/phd/epidemics/), Ministry of Health of New Zealand (www.health.govt.nz), Direction des Affaires Sanitaires et Sociales New Caledonia (http://www.dass.gouv.nc/portal/page/portal/dass/), Direction of Health French Polynesia (http://www.hygiene-publique.gov.pf/spip.php?article120), or from reports by the Pacific Islands health authorities on the results of molecular tests done at Institut Louis Malardé, French Polynesia, as part of the outbreaks investigations supported by WHO.
View Large Image | View Hi-Res Image | Download PowerPoint Slide
In 2007, the Yap State, the Federated States of Micronesia reported the first outbreak of Zika virus outside of Africa and Asia.5 Subsequent infections of Zika virus in other Pacific islands were not reported until 2013, when this virus reappeared in French Polynesia and then disseminated throughout the Pacific.4 The first autochthonous chikungunya infections in the region were reported in 2011 in New Caledonia. Chikungunya outbreaks occurred in Papua New Guinea in 2012, the Yap State in 2013, and Tonga, American Samoa, Samoa, and Tokelau in 2014.
Tropical oceanic regions host potential vectors for many arboviruses that local populations are mostly naive for, making these regions an ideal setting for such emerging viruses to spread; thus greatly contributing to the globalisation of dengue, chikungunya, and Zika viruses as threats to public health.
We declare no competing interests.
We thank Anita Teissier and Claudine Roche for doing molecular tests on specimens received from Pacific Island Countries. We thank Eric Nilles, Division of Pacific Technical support, WHO, and laboratory staff and public health authorities from Pacific island countries for doing laboratory investigations and sharing information. We thank WHO for support for molecular testing.
References
Are three drugs for malaria better than two?
Friday, 24th of April 2020 |
Public health Interventions and epidemic intensity during the 1918 influenza pandemic
Thursday, 16th of April 2020 |
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Tuesday, 17th of March 2020 |
Using models to shape measles control and elimination strategies in low- and middle-income countries: A review of recent applications
Monday, 17th of February 2020 |
Immunization Agenda 2030
Tuesday, 11th of February 2020 |
40758926 |
www.measlesinitiative.org www.technet21.org www.polioeradication.org www.globalhealthlearning.org www.who.int/bulletin allianceformalariaprevention.com www.malariaworld.org http://www.panafrican-med-journal.com/ |